BELKYRATM is an innovative injectable treatment that can be administered in roughly 15 to 20 minutes. This treatment is personalized for each patient’s needs and delivers permanent results. BELKYRATM, under its American moniker, Kybella®, received U.S. Food and Drug Administration approval in 2015. Once optimal results have been achieved, retreatment will not be required. Please note that results obtained with this treatment may vary from patient to patient.
Book a free† consultation today to see if this treatment is right for you.
†Please note that you must prepare a $75 fee for your initial consultation, as this will not be covered by the RAMQ. However, you will be reimbursed this cost at your next appointment. We will credit you this amount on your next treatment, for a total of up to $75.